Cargando…

Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?

INTRODUCTION: Nursing-home residents are among the highest risk group in the SARS-CoV-2 pandemic. At the onset of the SARS-CoV-2 pandemic, the majority of all deaths from or with SARS-CoV-2 occurred in long-term care facilities (LTCFs), so that maximum protective measures were mandated for these fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Heudorf, Ursel, Domann, Eugen, Förner, Markus, Kunz, Sabine, Latasch, Leo, Trost, Bernd, Steul, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978453/
https://www.ncbi.nlm.nih.gov/pubmed/36875328
http://dx.doi.org/10.3205/dgkh000431
_version_ 1784899524006772736
author Heudorf, Ursel
Domann, Eugen
Förner, Markus
Kunz, Sabine
Latasch, Leo
Trost, Bernd
Steul, Katrin
author_facet Heudorf, Ursel
Domann, Eugen
Förner, Markus
Kunz, Sabine
Latasch, Leo
Trost, Bernd
Steul, Katrin
author_sort Heudorf, Ursel
collection PubMed
description INTRODUCTION: Nursing-home residents are among the highest risk group in the SARS-CoV-2 pandemic. At the onset of the SARS-CoV-2 pandemic, the majority of all deaths from or with SARS-CoV-2 occurred in long-term care facilities (LTCFs), so that maximum protective measures were mandated for these facilities. This study analyzed the impact of the new virus variants and the vaccination campaign on disease severity and mortality among nursing home residents and staff through 2022 as a basis for determining which protective measures remain necessary and appropriate. METHODS: In five homes in Frankfurt am Main, Germany, with a total capacity for 705 residents, all cases occurring in the facility among residents and staff were recorded and documented (date of birth and diagnosis, hospitalization and death, vaccination status) and were descriptively analyzed with SPSS. RESULTS: By 31(st) August 2022, 496 residents tested positive for SARS-CoV-2, 93 in 2020, 136 in 2021, and 267 in 2022; 14 residents presented with a second SARS-CoV-2 infection in 2022, having previously experienced an infection in 2020 or 2021. The percentage of hospitalizations decreased from 24.7% (2020) and 17.6% (2021) to 7.5% (2022), and the percentage of deaths decreased from 20.4% and 19.1% to 1.5%. In 2021, 61.8% of those infected were vaccinated (at least 2x); in 2022, 86.2% of residents had been vaccinated twice, 84% of whom had already had a booster vaccination. Hospitalization and death rates were significantly higher among the unvaccinated than the vaccinated throughout all years (unvaccinated 21.5% and 18.0%; vaccinated 9.8% and 5.5%; KW test p=0.000). However, this difference was no longer significant under the prevalence of the Omicron variant in 2022 (unvaccinated 8.3% and 0%; p=0.561; vaccinated 7.4% and 1.7%; p=0.604). From 2020 to 2022, 400 employees were documented as infected, with 25 having second infections in 2022. Only one employee showed a second infection in 2021 following the first in 2020. Three employees were hospitalized; no deaths occurred. DISCUSSION AND CONCLUSION: Severe COVID-19 courses occurred with the Wuhan Wild type in 2020, with a high death rate among nursing-home residents. In contrast, during the waves in 2022 with the relatively mildly pathogenic Omicron variant, many infections but few severe courses and deaths were observed among the now mostly vaccinated and boostered nursing-home residents. Given the high immunity of the population and the low pathogenicity of the circulating virus – even in nursing-home residents – protective measures in nursing homes that restrict people’s right to self-determination and quality of life no longer seem justified. Instead, the general hygiene rules and the recommendations of the KRINKO (German Commission for Hospital Hygiene and Infection Prevention) on infection prevention should be followed, and the recommendations of the STIKO (German Standing Commission on Vaccination) on vaccination not only against SARS-CoV-2 but also against influenza and pneumococci should be observed.
format Online
Article
Text
id pubmed-9978453
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-99784532023-03-03 Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required? Heudorf, Ursel Domann, Eugen Förner, Markus Kunz, Sabine Latasch, Leo Trost, Bernd Steul, Katrin GMS Hyg Infect Control Article INTRODUCTION: Nursing-home residents are among the highest risk group in the SARS-CoV-2 pandemic. At the onset of the SARS-CoV-2 pandemic, the majority of all deaths from or with SARS-CoV-2 occurred in long-term care facilities (LTCFs), so that maximum protective measures were mandated for these facilities. This study analyzed the impact of the new virus variants and the vaccination campaign on disease severity and mortality among nursing home residents and staff through 2022 as a basis for determining which protective measures remain necessary and appropriate. METHODS: In five homes in Frankfurt am Main, Germany, with a total capacity for 705 residents, all cases occurring in the facility among residents and staff were recorded and documented (date of birth and diagnosis, hospitalization and death, vaccination status) and were descriptively analyzed with SPSS. RESULTS: By 31(st) August 2022, 496 residents tested positive for SARS-CoV-2, 93 in 2020, 136 in 2021, and 267 in 2022; 14 residents presented with a second SARS-CoV-2 infection in 2022, having previously experienced an infection in 2020 or 2021. The percentage of hospitalizations decreased from 24.7% (2020) and 17.6% (2021) to 7.5% (2022), and the percentage of deaths decreased from 20.4% and 19.1% to 1.5%. In 2021, 61.8% of those infected were vaccinated (at least 2x); in 2022, 86.2% of residents had been vaccinated twice, 84% of whom had already had a booster vaccination. Hospitalization and death rates were significantly higher among the unvaccinated than the vaccinated throughout all years (unvaccinated 21.5% and 18.0%; vaccinated 9.8% and 5.5%; KW test p=0.000). However, this difference was no longer significant under the prevalence of the Omicron variant in 2022 (unvaccinated 8.3% and 0%; p=0.561; vaccinated 7.4% and 1.7%; p=0.604). From 2020 to 2022, 400 employees were documented as infected, with 25 having second infections in 2022. Only one employee showed a second infection in 2021 following the first in 2020. Three employees were hospitalized; no deaths occurred. DISCUSSION AND CONCLUSION: Severe COVID-19 courses occurred with the Wuhan Wild type in 2020, with a high death rate among nursing-home residents. In contrast, during the waves in 2022 with the relatively mildly pathogenic Omicron variant, many infections but few severe courses and deaths were observed among the now mostly vaccinated and boostered nursing-home residents. Given the high immunity of the population and the low pathogenicity of the circulating virus – even in nursing-home residents – protective measures in nursing homes that restrict people’s right to self-determination and quality of life no longer seem justified. Instead, the general hygiene rules and the recommendations of the KRINKO (German Commission for Hospital Hygiene and Infection Prevention) on infection prevention should be followed, and the recommendations of the STIKO (German Standing Commission on Vaccination) on vaccination not only against SARS-CoV-2 but also against influenza and pneumococci should be observed. German Medical Science GMS Publishing House 2023-02-14 /pmc/articles/PMC9978453/ /pubmed/36875328 http://dx.doi.org/10.3205/dgkh000431 Text en Copyright © 2023 Heudorf et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Heudorf, Ursel
Domann, Eugen
Förner, Markus
Kunz, Sabine
Latasch, Leo
Trost, Bernd
Steul, Katrin
Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title_full Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title_fullStr Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title_full_unstemmed Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title_short Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020–2022: What protective measures are still required?
title_sort development of morbidity and mortality of sars-cov-2 in nursing homes for the elderly in frankfurt am main, germany, 2020–2022: what protective measures are still required?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978453/
https://www.ncbi.nlm.nih.gov/pubmed/36875328
http://dx.doi.org/10.3205/dgkh000431
work_keys_str_mv AT heudorfursel developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT domanneugen developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT fornermarkus developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT kunzsabine developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT lataschleo developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT trostbernd developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired
AT steulkatrin developmentofmorbidityandmortalityofsarscov2innursinghomesfortheelderlyinfrankfurtammaingermany20202022whatprotectivemeasuresarestillrequired